Skip to content
akaturk Academic measurement

Academician

BANU İSKENDER İZGİ

Doçent

Kocaeli Üniversitesi Tıp Fakültesi Temel Tıp Bilimleri Bölümü

  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Biyoloji
Articles 20 YÖKSİS 20 · OpenAlex 0 Total citations 242 h-index 7 · OpenAlex Q1 articles 10 Scopus · WoS Q1 3 Best field rank #15,438 / 39,749 Main field · top 38.8% Co-authors 43 3 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 1 + YÖKSİS · co-author record: 7
h-index 7 Percentile in Türkiye: 8 #531 of 913 at their university by h-index
i10-index
7
Total citations
242
Top 92% in Türkiye
Per article
30.2
FWCI
3.88
1.00 = world average
World top 1%
0
World top 10%
3
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 7 articles (241 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
43
With an akaturk profile
7
Turkish institutions
3
Co-authored works
%95

Academic co-authors 7

  1. HALİT CANATAN Profesör · Erciyes Üniversitesi 13
  2. GÜRLER AKPINAR Profesör · Kocaeli Üniversitesi same university 2
  3. MEHMET SARIHAN Doktor Öğretim Üyesi · Kocaeli Üniversitesi same university 2
  4. MURAT KASAP Profesör · Kocaeli Üniversitesi same university 2
  5. MUSTAFA ÇAKIR Doktor Öğretim Üyesi · Van Yüzüncü Yıl Üniversitesi 2
  6. BERKAY SARAYMEN Öğretim Görevlisi (uygulamalı Birim) · Erciyes Üniversitesi 1
  7. SALİH ŞANLIOĞLU Profesör · Akdeniz Üniversitesi 1

National collaboration 3 institutions

Within own university2 joint works · Kocaeli Üniversitesi

  1. Erciyes Üniversitesi 13 works · 2 academics
  2. Van Yüzüncü Yıl Üniversitesi 2 works · 1 academics
  3. Akdeniz Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 36

KENAN İZGİ 12ÇAĞRI ŞAKALAR 5Aslıhan Arslanhan 3BENGİ SU RUMEYSA BARLAK 3Susan J. Kimber 3Esra Hilal Yüksek 2Esra Hızar 2Johann Jauch 2Melissa A. Baxter 2SEDAT SEZEN 2Adam ByronAli TuranBüşra KurtDaniel R BrisonDavid KnightDespina SoteriouDuncan MillerHALİT KARACAHuriye AksuJayne C FitzsimmonsJinpei YeJohn AplinJonathan D. HumphriesLoriana VitilloMEHMET FATİH SÖNMEZMaria V CamarasaMarie-Claire HaddockMartin J. HumphriesMaël CharpentierNicola BatesPaul WhitingSimon Borg-BartoloTristan R McKayTyson V Sharpdaniel foxlermaureen mee

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 1 articles
OpenAlex citation percentile
Top 1%0
Top 10%0
Avg · n 1 %50.4
Other counts

Scopus (SJR)

  • YÖKSİS rows 19

WoS (JCR)

  • YÖKSİS rows 19

TR Index

  • YÖKSİS rows 2 articles

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

20articles

Journals with publications

16 journals

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article list

  1. 2026 Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades. Cancer genomics & proteomics DOI 10.21873/cgp.20601 YÖKSİS SJR Q2 JCR Q2
  2. 2026 Conjoining cell reprogramming and mass spectrometry to identify the proteomic variations in the reprogrammed bladder cancer cells: finding cues of normalisation BMC CANCER DOI 10.1186/s12885-026-15634-x YÖKSİS SJR Q2 JCR Q2
  3. 2026 Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity CANCER GENOMICS & PROTEOMICS DOI 10.21873/cgp.20578 YÖKSİS SJR Q2 JCR Q2
  4. 2022 The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling MEDENIYET MEDICAL JOURNAL DOI 10.4274/MMJ.galenos.2022.68915 2 YÖKSİS records YÖKSİS TR Index SJR Q4 JCR Q2
  5. 2017 Current status in cancer cell reprogramming and its clinical implications. Journal of cancer research and clinical oncology DOI 10.1007/s00432-016-2258-5 YÖKSİS SJR Q1 JCR Q2
  6. 2017 Long Term Exposure to Myrtucommulone-A Changes CD105 Expression and Differentiation Potential of Mesenchymal Stem Cells TISSUE ENGINEERING AND REGENERATIVE MEDICINE DOI 10.1007/s13770-016-0020-3 YÖKSİS SJR Q3 JCR Q4
  7. 2017 Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY DOI 10.2174/1871520616666160404110543 YÖKSİS SJR Q2 JCR Q3
  8. 2016 The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer TUMOR BIOLOGY DOI 10.1007/s13277-015-4307-0 YÖKSİS SJR Q1 JCR Q2
  9. 2016 Reprogramming bladder cancer cells for studying cancer initiation and progression TUMOR BIOLOGY DOI 10.1007/s13277-016-5226-4 YÖKSİS SJR Q1 JCR Q2
  10. 2016 Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis MOLECULAR AND CELLULAR BIOCHEMISTRY DOI 10.1007/s11010-016-2697-y YÖKSİS SJR Q1 JCR Q3
  11. 2016 Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling TUMOR BIOLOGY DOI 10.1007/s13277-015-4695-1 YÖKSİS SJR Q1 JCR Q2
  12. 2016 Integrin-Associated Focal Adhesion Kinase Protects Human Embryonic Stem Cells from Apoptosis, Detachment, and Differentiation STEM CELL REPORTS DOI 10.1016/j.stemcr.2016.07.006 YÖKSİS SJR Q1 JCR Q1
  13. 2016 Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway? TUMOR BIOLOGY DOI 10.1007/s13277-015-3995-9 YÖKSİS SJR Q1 JCR Q2
  14. 2015 Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9 JOURNAL OF NATURAL MEDICINES DOI 10.1007/s11418-015-0923-7 YÖKSİS SJR Q1 JCR Q3
  15. 2015 Evaluation of two different adjuvants with immunogenic uroplakin 3A-derived peptide for their ability to evoke an immune response in mice EUROPEAN CYTOKINE NETWORK DOI 10.1684/ecn.2015.0365 YÖKSİS SJR Q2 JCR Q3
  16. 2015 Myrtucommulone-A Induces both Extrinsic and Intrinsic Apoptotic Pathways in Cancer Cells JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY DOI 10.1002/jbt.21716 YÖKSİS SJR Q2 JCR Q2
  17. 2014 Human Embryonic Stem Cells And Microenvironment Journal of Clinical and Experimental Investigations YÖKSİS OpenAlex 50.4%
  18. 2013 Comparative Proteomic Analysis of Supportive and Unsupportive Extracellular Matrix Substrates for Human Embryonic Stem Cell Maintenance JOURNAL OF BIOLOGICAL CHEMISTRY DOI 10.1074/jbc.M113.463372 YÖKSİS SJR Q1 JCR Q1
  19. 2013 Induced pluripotent stem cells and cell therapy İndüklenmiş pluripotent kök hücreler ve hücre tedavisi Journal of Clinical and Experimental Investigations YÖKSİS
  20. 2011 Human feeder cell line for derivation and culture of hESc/hiPSc STEM CELL RESEARCH DOI 10.1016/j.scr.2011.04.005 YÖKSİS SJR Q1 JCR Q1

← Back to academicians